Related Experiment Video
Updated: Jul 16, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Grb2 is required for atherosclerotic lesion formation
Brandon M Proctor1, Jie Ren, Zhouji Chen
1Center for Cardiovascular Research, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO 63110, USA.
Grb2 adapter protein deficiency in mice reduces atherosclerosis development. This suggests Grb2 is crucial for macrophage foam cell formation and MAPK activation, key in atherosclerosis progression.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Immunology
Background:
- Grb2 is a linker protein activating mitogen-activated protein kinase (MAPK) cascades.
- MAPK activation is vital for macrophage proliferation and modified lipoprotein uptake in atherogenesis.
- The role of Grb2 in atherosclerosis pathogenesis is unclear.
Purpose of the Study:
- To investigate the role of the Grb2 adapter protein in atherosclerotic lesion formation.
- To generate and study Grb2 heterozygous (Grb2+/-) mice in an apolipoprotein E knockout (apoE-/-) background.
Main Methods:
- Generated Grb2+/- apoE-/- mice.
- Assessed atherosclerotic lesion formation using aortic sinus and en face assays.
- Performed bone marrow transplantation experiments.
- Conducted cell culture experiments with bone marrow-derived macrophages.
Main Results:
- Grb2+/- apoE-/- mice showed reduced atherosclerotic lesion formation on a Western diet compared to apoE-/- mice.
- Grb2 haploinsufficiency in blood-borne cells conferred resistance to atherosclerosis.
- Grb2 was essential for oxidized low-density lipoprotein (oxLDL)-induced MAPK activation and foam cell formation in macrophages.
Conclusions:
- Grb2 is required for atherosclerotic lesion development.
- Grb2 plays a critical role in the uptake of oxidized LDL by macrophages, a key process in atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Inflammation
Peripheral Artery Disease I: Introduction

